Showing 12,541 - 12,560 results of 100,273 for search '(( 5 ((((we decrease) OR (a decrease))) OR (nn decrease)) ) OR ( 50 ms decrease ))', query time: 1.67s Refine Results
  1. 12541
  2. 12542
  3. 12543
  4. 12544
  5. 12545
  6. 12546

    Proliferative keratinocytes and BrdU-positive label retaining cells are decreased in <i>Med1<sup>epi−/−</sup></i> mice. by Fumihito Noguchi (615295)

    Published 2014
    “…<p>A: Images show representative high-power fields of immunohistochemistry for Ki67 in 6-month-old wild-type and <i>Med1<sup>epi−/−</sup></i> mice keratinocytes in the transitional epidermis and the migrating epithelial tongues on days 1, 3 and 5 after injury. …”
  7. 12547

    Impact of Weak Agostic Interactions in Nickel Electrocatalysts for Hydrogen Oxidation by Christina M. Klug (4107286)

    Published 2017
    “…However, the decrease in catalytic rate is accompanied by a beneficial 130 mV decrease in overpotential.…”
  8. 12548

    Baseline characteristics of the study population. by Hae In Jung (18137024)

    Published 2024
    “…</p><p>Conclusions</p><p>As problems indicated by EQ-5D worsened, there was a consistent decrease in handgrip strength (HGS) across both genders. …”
  9. 12549
  10. 12550
  11. 12551
  12. 12552
  13. 12553
  14. 12554
  15. 12555

    Expression of SPDEF in TRAMP C2 prostate adenocarcinoma cells decreased cell growth, reduced migration and colony formation on soft agar. by Xin-Hua Cheng (154368)

    Published 2014
    “…<p><b>A</b>. qRT-PCR shows that <i>SPDEF</i> mRNA is increased in SPDEF OE cells (left panel). …”
  16. 12556

    Significantly decreased levels of CD4<sup>+</sup>CD25<sup>+</sup> Treg cells in arthropathic Tax transgenic mice. by Takeo Ohsugi (225723)

    Published 2011
    “…(B) The majority of CD4<sup>+</sup>CD25<sup>+</sup> T cells in non-transgenic mice expressed a high level of Foxp3 (81.2±1.4%), whereas half of CD4<sup>+</sup>CD25<sup>+</sup> T cells in arthropathic Tax transgenic mice did not express Foxp3 (50.2±5.2%) (n = 6 per group), *** <i>P</i><0.001. …”
  17. 12557

    Wounds treated with sDll4-Fc have increased vascular density but decreased vascular maturation in direct proportion to the dosage level. by Alexandre Trindade (187498)

    Published 2012
    “…C,D,E) Representative anti-PECAM and anti-SMA immunofluorescence images of neo-vasculature in granulation tissue of wounds treated with (D) 0,05 mg/kg or (E) 2,5 mg/kg compared with control mice injected with PBS (C), in days 2, 4 and 6. sDll4-Fc therapy leads to decreased smooth muscle cell recruitment and increased vascular density that is directly proportional to the administered dosage. * In graphics represents p<0,05.…”
  18. 12558
  19. 12559
  20. 12560

    BC−/EC+ exhibited increased end-systolic and end-diastolic volume and decreased left ventricular function 3 weeks post MI. by Simone Gorressen (605474)

    Published 2015
    “…<p>BC−/EC+ exhibited an increase in end-systolic (<b>A</b>) and end-diastolic volume (<b>B</b>), a significantly more pronounced decrease in stroke volume (<b>C</b>) (BC+/EC+ n = 8 and BC−/EC+ n = 5; two-way ANOVA and Bonferroni’s post hoc test or student’s t-test; * p<0.05, ** p≤ 0.01 BC+/EC+ vs. …”